Compare Crispr Therapeutics AG (CRSP) vs Wolfspeed Inc (WOLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Wolfspeed Inc — how do they compare? Crispr Therapeutics AG trades at $53.42 (market cap $4.88B), while Wolfspeed Inc trades at $30.29 (market cap $1.64B). The key difference: Crispr Therapeutics AG is far larger — about 3× Wolfspeed Inc's market cap, and Wolfspeed Inc is more actively traded (22,772,687 versus 2,861,747). Which is the better fit depends on your goals — on Pluang, investors hold Crispr Therapeutics AG for 77 Days and Wolfspeed Inc for 19 Days on average.
| CRSP | WOLF | |
|---|---|---|
Market Cap | $4.88B | $1.64B |
Volume | 2,861,747 | 22,772,687 |
Sector | Health | Technology |
52-Week High | $74.92 | $73.68 |
52-Week Low | $44.34 | $14.80 |
Typical Hold Time | 77 Days | 19 Days |
Enterprise Value | $3.30B | $2.35B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRISPR Therapeutics (CRSP) trades at $53.41, up 2.02% with a bearish technical signal despite recent earnings beats. The company shows negative profitability metrics with -$581.60M net income in 2025 and revenue volatility, though analyst consensus remains bullish with a $67.83 price target. Key catalysts include upcoming clinical data presentations for autoimmune disease therapies and CASGEVY commercialization progress.
The stock presents high-risk, high-reward potential with strong Wall Street support (57.9% buy ratings) but faces significant execution risks. Near-term performance hinges on clinical trial outcomes and revenue generation from approved therapies, while persistent cash burn and competitive pressures remain key concerns for investors.
Wolfspeed (WOLF) trades at $30.62, down 2.39% today, with a bullish technical signal supported by moving averages. The company shows improving quarterly earnings performance with recent beats, though 2025 fundamentals reveal significant losses (-$1.61B net income) and negative margins. Recent news highlights expansion of 200mm silicon carbide substrates and AI infrastructure exposure. Analyst consensus price target sits at $54.32, representing 77% upside potential from current levels.
Wolfspeed presents a high-risk, high-reward opportunity with strong analyst upside potential but substantial fundamental challenges. The company's path to profitability depends on successful execution of its silicon carbide technology roadmap and achieving breakeven revenue targets. Near-term volatility is expected given ongoing operational challenges and investor investigations, while long-term prospects hinge on AI infrastructure adoption.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Wolfspeed Inc
Wolfspeed is the global leader in wide bandgap semiconductors, specializing in silicon carbide (SiC) and gallium nitride (GaN) materials and devices. It operates a vertically integrated model, controlling the entire process from raw material substrate production to advanced power modules, serving as a critical infrastructure provider for electric vehicles (EVs), renewable energy, and AI data centers.
Read more on WOLF →
